Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Moschus berezovskii musk sac resin is an animal extract derived from the glandular secretion of the forest musk deer (Moschus berezovskii), a species native to southern and central China and northern Vietnam. The substance, commonly referred to as "musk," is a brown solid with a characteristic fragrance, secreted by adult male deer primarily for territorial marking and attracting females during breeding season. The main components of this natural product include steroid hormones, proteins, amino acids, and various volatile organic compounds. It has been used in traditional medicine formulations and some over-the-counter products but is not an approved pharmaceutical drug in major regulatory jurisdictions[1][5][8]. Its mechanism of action is not well characterized; it may exert effects through its complex mixture of bioactive molecules including steroids that could influence hormonal or neurological pathways[6][8]. There are no known modern pharmaceutical developers or manufacturers associated with this substance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on moschus berezovskii musk sac resin.